Early progress on accelerating drug development with Claude
- Anthropic’s life sciences team is working to accelerate curing disease.
- Over the past several months, our scientists have engaged in deep research partnerships with six organizations developing new medicines: BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.
- We've also begun drug discovery efforts of our own.
Unverified
- Anthropic’s life sciences team is working to accelerate curing disease.
- Over the past several months, our scientists have engaged in deep research partnerships with six organizations developing new medicines: BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.
- We've also begun drug discovery efforts of our own.
Sources: Anthropic